Conhecimentos, atitudes e práticas dos profissionais de saúde acerca do tratamento da infecção latente pelo Mycobacterium tuberculosis

• Ano de defesa: 2022
• Autor(a) principal: Costa, Ana Paula Rodrigues
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal do Espírito Santo; BR; Mestrado em Saúde Coletiva; Centro de Ciências da Saúde; UFES; Programa de Pós-Graduação em Saúde Coletiva
• Palavras-chave em Português: Infecção Latente pelo Mycobacterium tuberculosis; Conhecimentos; Atitudes e Prática em Saúde; Isoniazida; subject.br-rjbn; Saúde Coletiva
• Link de acesso: http://repositorio.ufes.br/handle/10/16178

Latent Infection by Mycobacterium tuberculosis (LTBI) affects a quarter of the world's population. It is defined as a state of persistent immune response to stimulation by Mycobacterim tuberculosis (MTB) antigens without evidence of active disease. Objective: To analyze knowledge, attitudes and practices (KAP) of the Treatment of Latent Infection by Mycobacterium tuberculosis by health professionals in primary care and in Tuberculosis treatment units. Methods: Cross-sectional study on knowledge, attitudes and practices, carried out with 17 prescribers and 37 dispensers of LTBI treatment, where a semi-structured questionnaire was applied, organized into three blocks that addressed the sociodemographic situation and general data, aspects related to knowledge about LTBI, and prescribing or dispensing Isoniazid (H) in the health unit. Results: There was a predominance of females in both categories, with nurses prescribing LTBI treatment. Non-pharmaceutical professionals (doctor, nurse, mid-level nursing and pharmacy) dispensing Isoniazid. Prescribers have less than 03 years of professional experience, unlike dispensers who are more experienced. Both have been working for less than 03 years in the current health unit and most have not been trained in LTBI. There is adequate knowledge of prescribers and dispensers about the indication of H for LTBI and primary LTBI treatment, Tuberculosis (TB) control strategies, treatment indication criteria, there is guidance on the drug and its use, and there was a knowledge gap of prescribers on BCG vaccination in the newborn who lives with a mother with TB. The dispensing attitude of H 300mg was inappropriate. Conclusion: It is necessary to promote continuing education for professionals so that they are sensitized and trained in the care of users undergoing LTBI treatment.